uniQure (QURE) Work In Process (2022 - 2024)

uniQure's (QURE) quarterly Work In Process came in at $1.3 million in Q1 2024, down 67.36% quarter-over-quarter from $4.1 million in Q4 2023.

uniQure (QURE) Work In Process (2022 - 2024) Analysis & Trends

uniQure's Work In Process history runs 3 years deep, the most recent figure standing at $1.3 million for Q1 2024.

  • On a quarterly basis, Work In Process changed N/A year-over-year to $1.3 million in Q1 2024; TTM through Mar 2024 was $1.3 million, a N/A change from a year earlier, with the FY2023 full-year figure at $4.1 million, up 119.26% from the prior year.
  • Work In Process fell to $1.3 million in Q1 2024 per QURE's latest filing, from $4.1 million in the prior quarter.
  • Across five years, Work In Process topped out at $6.6 million in Q3 2023 and bottomed at $1.3 million in Q1 2024.
  • The 3-year median for Work In Process is $3.1 million (2022), against an average of $3.4 million.
  • Biggest YoY gain for Work In Process was 202.89% in 2023; the steepest drop was 119.26% in 2023.
  • Year by year, Work In Process stood at $1.9 million in 2022, then jumped by 119.26% to $4.1 million in 2023, then tumbled by 67.36% to $1.3 million in 2024.
  • Per Business Quant, the three latest QURE Work In Process figures stand at $1.3 million (Q1 2024), $4.1 million (Q4 2023), and $6.6 million (Q3 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 uniQure 2.47 Bn 2.47 Bn 3.34 Mn

Historic Data

Download Data
DateValue
Mar 31, 2024 1.34 Mn
Dec 31, 2023 4.11 Mn
Sep 30, 2023 6.60 Mn
Jun 30, 2023 4.06 Mn
Dec 31, 2022 1.87 Mn
Sep 30, 2022 2.18 Mn